Ropinirole Alternatives Compared
| Ropinirole | Ingrezza (valbenazine) | Austedo (deutetrabenazine) |
|
|---|
| Ropinirole | Ingrezza (valbenazine) | Austedo (deutetrabenazine) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Ropinirole is used in the treatment of restless legs syndrome and Parkinson's disease; however, it may cause drowsiness which has caused some people to fall asleep while driving - do not drive if... View more |
Prescription only
Ingrezza may be used to treat adults with tardive dyskinesia or chorea associated with Huntington's disease. It works by blocking VMAT2, which reduces the uptake of dopamine by the brain. Although... View more |
Prescription only
Austedo may be used to treat Huntington’s chorea or tardive dyskinesia and works by blocking the action of VMAT2 which is a protein that controls the transfer of chemical messengers between nerves i... View more |
Related suggestions Tardive Dyskinesia
Popular comparisons
|
|||||||||||||||||||||||
| More about Ropinirole | More about Ingrezza (valbenazine) | More about Austedo (deutetrabenazine) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Ropinirole has an average rating of 6.4 out of 10 from a total of 330 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 27% reported a negative effect. |
Ingrezza has an average rating of 6.1 out of 10 from a total of 19 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 37% reported a negative effect. |
Austedo has an average rating of 6.5 out of 10 from a total of 12 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Ropinirole side effects |
View all Ingrezza side effects |
View all Austedo side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Ropinirole prices |
View all Ingrezza prices |
View all Austedo prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other valbenazine brands include: Ingrezza Sprinkle | Other deutetrabenazine brands include: Austedo XR | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
6 hours |
22 hours |
10 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 307 drugs are known to interact with Ropinirole:
|
A total of 509 drugs are known to interact with Ingrezza:
|
A total of 448 drugs are known to interact with Austedo:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
September 19, 1997 |
April 11, 2017 |
April 03, 2017 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Ingrezza
Ingrezza (valbenazine) is used to treat tardive dyskinesia (TD) and chorea associated with ...
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Rytary
Rytary is used to treat symptoms of Parkinson's disease and parkinsonism that may follow carbon ...
Azilect
Azilect (rasagiline) is used to treat the symptoms of Parkinson's disease. Learn about side ...
Crexont
Crexont (carbidopa and levodopa) is an extended-release capsule that may be used to treat symptoms ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.